Predicting enzyme targets for cancer drugs by profiling human Metabolic reactions in NCI-60 cell lines

Predicting enzyme targets for cancer drugs by profiling human Metabolic reactions in NCI-60 cell lines

<p>Abstract</p> <p>Background</p> <p>Drugs can influence the whole metabolic system by targeting enzymes which catalyze metabolic reactions. The existence of interactions between drugs and metabolic reactions suggests a potential way to discover drug targets.</p>...

Full description

Bibliographic Details
Main Authors:	Ching Wai-Ki, Zhou Xiaobo, Li Limin, Wang Ping
Format:	Article
Language:	English
Published:	BMC 2010-10-01
Series:	BMC Bioinformatics
Online Access:	http://www.biomedcentral.com/1471-2105/11/501

Similar Items

Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines
by: Tiannan Guo, et al.
Published: (2019-11-01)

Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data
by: Li Kuo-Bin, et al.
Published: (2009-05-01)

An integrated analysis of molecular aberrations in NCI-60 cell lines
by: Yeang Chen-Hsiang
Published: (2010-10-01)

Expression of microRNAs in the NCI-60 cancer cell-lines.
by: Santosh K Patnaik, et al.
Published: (2012-01-01)

Global Proteome Analysis of the NCI-60 Cell Line Panel
by: Amin Moghaddas Gholami, et al.
Published: (2013-08-01)

HLA class I and II genotype of the NCI-60 cell lines
by: Morse Herbert C, et al.
Published: (2005-03-01)

Proteins associated with the doubling time of the NCI-60 cancer cell lines
by: Michael Polymenis
Published: (2017-08-01)

A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines.
by: Maike K Aurich, et al.
Published: (2017-08-01)

In Search of Outliers. Mining for Protein Kinase Inhibitors Based on Their Anti-Proliferative NCI-60 Cell Lines Profile
by: George Nicolae Daniel Ion, et al.
Published: (2020-04-01)

Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data
by: Onyia Jude E, et al.
Published: (2006-07-01)

Nonlinear Quantitative Radiation Sensitivity Prediction Model Based on NCI-60 Cancer Cell Lines
by: Chunying Zhang, et al.
Published: (2014-01-01)

CellMiner: a relational database and query tool for the NCI-60 cancer cell lines
by: Reinhold William C, et al.
Published: (2009-06-01)

Gene expression profiles of the NCI-60 human tumor cell lines define molecular interaction networks governing cell migration processes.
by: Kurt W Kohn, et al.
Published: (2012-01-01)

Characterization of Growth Hormone Signaling in the NCI60 Cancer Panel
by: Sustarsic, Elahu Gosney
Published: (2013)

Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines.
by: Barry R Zeeberg, et al.
Published: (2012-01-01)

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
by: Bedognetti Davide, et al.
Published: (2011-10-01)

NCI-60 whole exome sequencing and pharmacological CellMiner analyses.
by: William C Reinhold, et al.
Published: (2014-01-01)

Molecular genomic features associated with in vitro response of the NCI‐60 cancer cell line panel to natural products
by: Julia Krushkal, et al.
Published: (2021-02-01)

Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen.
by: David G Covell
Published: (2012-01-01)

Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location.
by: Xiaoyang Ruan, et al.
Published: (2012-01-01)

Concordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples.
by: Barry R Zeeberg, et al.
Published: (2012-01-01)

Regioselective synthesis of triazolo[3,4-e]purine derivatives and their anti-cancer activity against NCI-60 cell-lines
by: Khushal Kapadiya, et al.
Published: (2021-04-01)

Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines
by: Jarjanazi Hamdi, et al.
Published: (2011-02-01)

Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.
by: Kira Philipsen Prahm, et al.
Published: (2017-01-01)

The effect of Nullomer-derived peptides 9R, 9S1R and 124R on the NCI-60 panel and normal cell lines
by: Abdelkrim Alileche, et al.
Published: (2017-08-01)

Modulators of sensitivity and resistance to inhibition of PI3K identified in a pharmacogenomic screen of the NCI-60 human tumor cell line collection.
by: Kevin A Kwei, et al.
Published: (2012-01-01)

Variations in Mre11/Rad50/Nbs1 status and DNA damage-induced S-phase arrest in the cell lines of the NCI60 panel
by: Eastman Alan, et al.
Published: (2011-05-01)

Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma.
by: Munirah Ahmad, et al.
Published: (2018-01-01)

High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner.
by: Sudhir Varma, et al.
Published: (2014-01-01)

A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance.
by: Sevtap Savas, et al.
Published: (2010-01-01)

Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
by: Pavel Sidorov, et al.
Published: (2019-07-01)

Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells
by: Kim Han, et al.
Published: (2012-07-01)

(Age)ncy in Composition Studies
by: Tackitt, Alaina
Published: (2017)

Study of the Relationship between Sigma Receptor Expression Levels and Some Common Sigma Ligand Activity in Cancer Using Human Cancer Cell Lines of the NCI-60 Cell Line Panel
by: Evangelia Sereti, et al.
Published: (2021-01-01)

Inhibitory effect of gypsogenin on NCI-N87 gastric cancer cell line
by: Yutao Liu, et al.
Published: (2018-12-01)

Intercellular contact-dependent survival of human A549, NCI-H596 and NCI-H520 non-small cell lung carcinoma cell lines
by: M.A.A. Castro, et al.
Published: (2001-08-01)

Toxoplasma gondii metabolic enzymes and their evaluation as antiparasitic drug targets
by: Mageed, Sarmad Nagemaldeen
Published: (2013)

NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells.
by: Sevtap Savas, et al.
Published: (2011-01-01)

Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma
by: Ahmad, M, et al.
Published: (2018)

Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma
by: Ahmad, M., et al.
Published: (2018)